Share price and capital
Share price and trading information for Solvonis Therapeutics plc (LSE: SVNS), and the Company’s issued share capital.
Trading information for LSE: SVNS
Share price chart
Trading history
Share price data is supplied by Brighter IR and may be delayed. Ordinary shares of £0.001 each are admitted to trading on the Main Market of the London Stock Exchange under the ticker SVNS.
Issued share capital and total voting rights
As at 30 September 2026, the Company’s issued share capital consists of 7,899,736,826 ordinary shares, none of which are held in treasury, so the total number of voting rights in the Company is 7,899,736,826. Ordinary shares have a nominal value of £0.001 each. There are no restrictions on the transfer of the Company’s securities, which are not admitted to trading on any other exchange. The Company is incorporated in England and Wales and is subject to the UK City Code on Takeovers and Mergers.
Shareholders may use this figure as the denominator for the calculations by which they determine whether they are required to notify their interest in, or a change to their interest in, the Company under the FCA’s Disclosure Guidance and Transparency Rules.
Source: Solvonis Therapeutics plc, Notification of Admission of Shares and TVR, RNS, 30 September 2026. Updated after each total voting rights announcement.
Significant shareholders
Shareholders holding 3% or more of the voting rights, as last notified to the Company.
| Shareholder | Ordinary shares | % of votes |
|---|---|---|
| Pamlico Shoals Targeted Opportunities Fund LP | 730,306,344 | 12.36% |
| William Potts | 610,461,538 | 10.33% |
Percentages are of 5,908,770,690 voting rights, the number in issue when this list was last updated. They have not been recalculated for shares issued since, and current holdings may differ.